Fisher Asset Management
RCUS icon

Fisher Asset Management’s Arcus Biosciences RCUS Stock Holding History

Fisher Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.3M Buy
2,190,404
+240,616
+12% +$5.2M 0.02% 244
2025
Q4 		$46.5M Buy
1,949,788
+1,220,635
+167% +$24.9M 0.02% 244
2025
Q3 		$9.92M Buy
729,153
+640,990
+727% +$6.66M ﹤0.01% 410
2025
Q2 		$718K Sell
88,163
-49,475
-36% -$423K ﹤0.01% 738
2025
Q1 		$1.08M Buy
+137,638
New +$1.6M ﹤0.01% 668

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Fisher Asset Management's RCUS Position: Q1 2026 in Review

Fisher Asset Management increased its Arcus Biosciences (RCUS) stake by 12% in Q1 2026, buying an estimated $5.2M and bringing the position to 2,190,404 shares worth $47.3M. The position accounts for 0.02% of the portfolio, ranked #244.

Fisher Asset Management first reported a position in RCUS in Q1 2025 and has held it in 5 quarters since. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Fisher Asset Management held 2,190,404 shares of Arcus Biosciences worth $47.3M as of Q1 2026.
  • Fisher Asset Management bought 240,616 Arcus Biosciences shares in Q1 2026, an estimated $5.2M.
  • Arcus Biosciences made up 0.02% of Fisher Asset Management's portfolio in Q1 2026, its #244 holding.
  • Fisher Asset Management first reported a position in Arcus Biosciences in Q1 2025 and has held it in 5 quarters since.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.